Susquehanna International Group
DICE

Susquehanna International Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Susquehanna International Group’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-143,900
Closed -$6.69M – 13425
2023
Q2 		$6.69M Buy
143,900
+114,300
+386% +$3.95M ﹤0.01% 3072
2023
Q1 		$848K Buy
29,600
+11,200
+61% +$332K ﹤0.01% 7254
2022
Q4 		$574K Sell
18,400
-13,700
-43% -$447K ﹤0.01% 7493
2022
Q3 		$651K Sell
32,100
-5,000
-13% -$91.1K ﹤0.01% 7751
2022
Q2 		$576K Buy
+37,100
New +$638K ﹤0.01% 7906

Susquehanna International Group's DICE Position: Q3 2023 in Review

Susquehanna International Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 22,056 shares — an estimated $1.02M sold.

Susquehanna International Group first reported a position in DICE in Q2 2022 and held it in 5 quarters. The position peaked at $2.93M in Q3 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Susquehanna International Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 22,056 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.02M.
  • Susquehanna International Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Susquehanna International Group's DICE Therapeutics, Inc. Common Stock position peaked at $2.93M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.